Ask AI

Addressing Challenges and Implementing Care Strategies to Optimize BCMA Bispecific Antibody Therapy in RRMM: Expert Insights, Patient Resources, and Adaptive Decision Support

Enhance your understanding of BCMA bispecific antibodies currently used to manage relapsed/refractory multiple myeloma to optimize therapy and improve adherence through an interactive decision support tool, certified interactive case challenge and on-demand webcast, expert-written ClinicalThought commentary, podcast, downloadable resources, and downloadable slides.

Share

Program Content

Events

  • Live Event
    Addressing Challenges and Implementing Care Strategies to Optimize BCMA Bispecific Antibody Therapy in RRMM: Expert Insights, Patient Resources, and Adaptive Decision Support
    Congratulations: You achieved a completion on 04/09/2022

    You can enroll in the following live event(s) on this topic.

Activities

MM BsAb Patient Resource
What I Wish I’d Known Before Starting Bispecific Antibody Therapy for Multiple Myeloma: A Patient Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: November 20, 2025

Activities

BsAb Challenge
Individualizing Therapy for Relapsed/Refractory Multiple Myeloma: Bispecific Antibody Therapy
Case Challenge
Congratulations: You achieved a completion on 04/09/2022

Released: December 31, 2025

Expires: June 30, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education in partnership with Smart Patients.

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer Inc.

Partners

Smart Patients

ProCE Banner